THE UNDERSTANDING NSW LONG-ACTING OPIOIDS IN CUSTODY-TREATMENT STUDY

被引：0

作者：

Dunlop, Adrian J. ^{[1
,2
,3
]}

Roberts, Jillian ^{[4
]}

White, Bethany ^{[5
,6
]}

Haber, Paul S. ^{[3
,5
,6
]}

Attia, John ^{[2
]}

Oldmeadow, Christopher ^{[2
]}

Searles, Andrew ^{[2
]}

Cretikos, Michelle A. ^{[7
]}

Mackson, Judith ^{[8
]}

Attalla, Dena ^{[4
]}

Murrell, Terry ^{[9
]}

Doyle, Michael ^{[10
]}

McEntyre, Elizabeth ^{[11
]}

Brown, Libby ^{[12
]}

Hussein, Hellal ^{[4
]}

Howard, Mark ^{[9
]}

Sequeira, Marcia ^{[1
]}

Lintzeris, Nicholas ^{[3
,6
,13
]}

机构：

[1] Hunter New England Local Hlth Dist, Drug & Alcohol Clin Serv, Newcastle, NSW, Australia

[2] Univ Newcastle, Hunter Med Res Inst, Newcastle, NSW, Australia

[3] NSW Drug & Alcohol Clin Res & Improvement Network, Sydney, NSW, Australia

[4] Justice Hlth & Forens Mental Hlth Network Drug Hl, Sydney, NSW, Australia

[5] Sydney Local Hlth Dist, Drug Hlth Serv, Sydney, NSW, Australia

[6] Univ Sydney, Discipline Addict Med, Sydney, NSW, Australia

[7] NSW Minist Hlth, Ctr Populat Hlth, Sydney, NSW, Australia

[8] NSW Minist Hlth, Legal & Regulatory Serv, Sydney, NSW, Australia

[9] Dept Commun & Justice, Correct Serv NSW, Sydney, NSW, Australia

[10] Univ Sydney, Discipline Addict Med, Wingara Mura Leadership Program, Sydney, NSW, Australia

[11] Durri Aboriginal Corp Med Serv, Kempsey, Australia

[12] Nepean Blue Mt Local Hlth Dist, Aboriginal Hlth Unit, Sydney, NSW, Australia

[13] South Eastern Sydney Local Hlth Dist, Drug & Alcohol Serv, Sydney, NSW, Australia

来源：

DRUG AND ALCOHOL REVIEW | 2019年 / 38卷

关键词：

D O I：

暂无

中图分类号：

R194 [卫生标准、卫生检查、医药管理];

学科分类号：

摘要：

引用

页码：S43 / S43

页数：1

共 50 条

[21] STUDY ON LONG-ACTING AKINESIA
TANAKA, H
MINAMI, M
KAWABE, H
FOLIA OPHTHALMOLOGICA JAPONICA, 1978, 29 (06): : 888 - 894
[22] Comparative Safety of Long-Acting Opioids for Non-Cancer Pain
Chung, Cecilia P.
Dupont, William
Murray, Katherine
Hall, Kathi
Stein, C. Michael
Ray, Wayne
ARTHRITIS & RHEUMATOLOGY, 2016, 68
[23] Comparative Safety of Long-Acting Opioids for Non-Cancer Pain
Chung, Cecilia P.
Dupont, William D.
Murray, Katherine T.
Hall, Kathi
Stein, C. Michael
Ray, Wayne A.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 583 - 583
[24] Rates of adverse events of long-acting opioids in a state Medicaid program
Hartung, Daniel M.
Middleton, Luke
Haxby, Dean G.
Koder, Michele
Ketchum, Kathy L.
Chou, Roger
ANNALS OF PHARMACOTHERAPY, 2007, 41 (06) : 921 - 928
[25] Re: Systematic review of long-acting oral opioids - Authors' response
Chou, R
Helfand, M
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2004, 28 (03) : 195 - 195
[26] Comment: therapy switching in patients receiving long-acting opioids - Reply
Oster, G
Berger, A
ANNALS OF PHARMACOTHERAPY, 2004, 38 (10) : 1753 - 1753
[27] Considerations in guidelines development -: Titrating opioids and converting to long-acting agents
Payne, R
ONCOLOGY-NEW YORK, 1999, 13 (11A): : 581 - 586
[28] Long-acting opioids for non-cancer pain increase mortality
Reactions Weekly, 2016, 1607 (1) : 11 - 11
[29] Daily Average Consumption of 2 Long-Acting Opioids and Coverage Decisions
Mitchell, Matthew
AMERICAN HEALTH AND DRUG BENEFITS, 2012, 5 (01): : 60 - 60
[30] Long-acting opioids for chronic noncancer pain were linked to mortality
Chou, Roger
ANNALS OF INTERNAL MEDICINE, 2016, 165 (06) : JC34 - JC34

← 1 2 3 4 5 →